SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-015813
Filing Date
2024-04-24
Accepted
2024-04-24 17:00:18
Documents
1
Period of Report
2024-04-22

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 8520
  Complete submission text file 0001493152-24-015813.txt   10596
Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139
Business Address
Lewis-Hall Freda C (Reporting) CIK: 0001437909 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41245 | Film No.: 24871362

Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Issuer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11421 GOLDEN EAGLE COURT NAPLES FL 34120
Business Address 11421 GOLDEN EAGLE COURT NAPLES FL 34120 3174967573
Intelmed LLC (Reporting) CIK: 0001994123 (see all company filings)

State of Incorp.: FL
Type: 4 | Act: 34 | File No.: 001-41245 | Film No.: 24871361